DB05473ExperimentalSmall molecule
QR-334 is under investigation for the treatment of sialorrhea. Sialorrhea is an excess secretion of saliva produced by the salivary glands, resulting in drooling. No pharmaceutical interventions currently exist to... The symptom is associated with many diseases including Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease, Cerebral Palsy, Parkinson's Disease, and Muscular Dystrophy.
- Mechanism
- Curator reviewed
unknown.
- Primary indication
- Investigated for use/treatment in saliva and salivary gland dysfunction (sialorrhea).Curator reviewed
- Code names
- QR-334
Which companies are running trials of QR-334, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account